Results 41 to 50 of about 885 (156)
Abstract Aims Sodium‐glucose co‐transporter 2 inhibitors have demonstrated cardiovascular benefits in individuals with type 2 diabetes mellitus, but the optimal timing of initiation in those with acute coronary syndrome is not known. This study aims to assess if early therapy at discharge is superior to delayed or no therapy in reduction in major ...
Muhammad Usman Shah +7 more
wiley +1 more source
ObjectiveAlthough an invasive strategy has been recommended within 24 h for patients with non-ST-segment elevation myocardial infarction (NSTEMI), the optimal timing of the invasive strategy remains controversial. We sought to investigate the association
Chuanxin Zhang (4819650) +7 more
core +1 more source
Az Europol-együttműködés tapasztalatai
Cél: Az írás célja a nemzetközi bűnügyi együttműködésben kiemelt szerepet betöltő Europol és Magyarország közötti együttműködés tapasztalatainak gyakorlati szempontú bemutatása.
Dániel Vetter
doaj +1 more source
Abstract Environmental crime is increasingly recognised as a transnational phenomenon requiring coordinated enforcement responses capable of addressing its cross‐border ecological, social and economic impacts. In this context, the strengthening of cross‐border police cooperation and specialised training has become particularly relevant within the EU ...
Maria Marques‐Banque
wiley +1 more source
Experience of the Europol cooperation
Aim: The aim of the article is to present the practical experience of cooperation between Europol, which plays a key role in international criminal cooperation, and Hungary.
Dániel Vetter
doaj +1 more source
Purpose To systematically review the efficacy and safety of dapagliflozin and sacubitril/valsartan (SV) in patients with heart failure (HF) following percutaneous coronary intervention (PCI)–treated acute myocardial infarction (AMI) and to provide evidence for clinical practice. Methods Seven electronic databases were systematically searched from their
Tang Tang +5 more
wiley +1 more source
We investigated cardiometabolic outcomes in patients treated with dapagliflozin 10 mg once daily or placebo after acute myocardial infarction according to LVEF at randomisation in the registry‐based, randomised DAPA‐MI trial. Regardless of baseline LVEF, dapagliflozin resulted in significant cardiometabolic benefits versus placebo, suggesting that ...
David Erlinge +19 more
wiley +1 more source
SGLT2 Inhibitors in Older Adults With Cardiovascular Disease: A Systematic Review and Meta‐Analysis
ABSTRACT Background Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors, developed for type 2 diabetes mellitus (T2DM), have demonstrated cardiorenal benefits in conditions including cardiovascular (CV) disease. However, few meta‐analyses have synthesized outcomes in older adults with CV disease.
Kota Minami +7 more
wiley +1 more source
Asymptomatic reduced left ventricular ejection fraction (LVEF) in the acute phase of myocardial infarction (AMI) was associated with up to 20% 1‐year mortality after discharge, substantially higher than in recent post‐MI trials. Symptoms of heart failure (HF) during the index hospitalization was associated with worse outcomes in patients with preserved
Jarle Jortveit +3 more
wiley +1 more source
Abstract Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors represent one of the main cornerstones of heart failure treatment. Nevertheless, while the cardiovascular beneficial effects of these drugs have been clearly demonstrated by several clinical trials, in clinical practice, it remains challenging to identify the appropriate timing to start SGLT2 ...
Ruggero Mazzotta +10 more
wiley +1 more source

